Mireille Gingras

Mireille A. Gingras (born 1963 in Montréal, Québec, Canada) founded HUYA Bioscience International, a biotech consulting firm, in 2004. She is president and chief executive officer of HUYA, which is headquartered in San Diego, California, with offices in Pudong, Shanghai, China.^[1]

Gingras is by education a neurobiologist. In 2010 her interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.^[2] Gingras received her Ph.D. from Radboud University Nijmegen and has held postdoctoral fellowships at Bordeaux University in France and The Scripps Research Institute in La Jolla, California. She received her bachelor of arts degree from Montréal's Concordia University.^[3]

Also one of the founders of MIR3,^[4] Gingras is a "serial entrepreneur" as she has described herself. She is single.^[5] Gingras is at least functional in several languages, including Mandarin, in addition to her native French.^[6]

Gingras has articulated five points of advice for women who want to succeed in biotechnology as a male-dominated profession:^[7]

- 1. Commit to building and growing your career

- 2. Know your industry, and look for opportunities that would play to women’s strengths

- 3. Move away from your comfort zone when networking

- 4. Maintain a balance between drive and patience

- 5. Speak directly and with confidence

Notes

1. ^ Welcome Message from CEO and founder Mireille Gingras, PhD (accessed 2010-11-06). See also Poh, Alissa (2008-11-13). "HUYA: A conduit between Chinese pharma and US clinical trials". PharmaWeek. http://www.ecliniqua.com/PharmaWeek_Article.aspx?id=84900&LangType=1033. Retrieved 2010-11-06. 
2. ^ Powell, Bill (2010-11-15). "Biotech pioneers: How two unlikely partners plan to unleash China's young pharma industry". Fortune 182 (8): pp. 49–50, 52. http://tech.fortune.cnn.com/2010/11/05/chinas-biotech-pioneers/?section=money_topstories. Retrieved 2010-11-06.  The quotation appears on p. 50.
3. ^ HUYA's management team (accessed 2010-11-06).
4. ^ HUYA profile on Bloomberg Business Week (accessed 2010-11-06). See also the MIR3 site.
5. ^ Dolgin, Elie (2009 June). "Year of the compound: Will a novel codevelopment model open up China's drug discovery platform?". Scientist 23 (6): p. 57. http://www.the-scientist.com/article/print/55717/. Retrieved 2010-11-06.  The article explains that the name HUYA comes from the "Chinese abbreviations for Shanghai (Hù) and Asia (Yà)"; the name is pronounced in English like WHO YA with equal stress on both syllables (/'hu·'ja/).
6. ^ David, Gollaher; Gingras, Mirielle (2010-02-09). "HUYA Bioscience International". CHI: Advancing Califonria Biomedical Research and Innovation. http://californiahealthcareinstitute.blogspot.com/2010/02/huya-bioscience-international.html. Retrieved 2010-11-06. 
7. ^ Wilson, Elizabeth. "How to establish yourself in a male-dominated field: biotechnology". Women Entrepreneur. http://excelle.monster.com/benefits/articles/1860-how-to-establish-yourself-in-a-male-dominated-field. Retrieved 2010-11-08. 

Persondata
Name	Gingras, Mireille
Alternative names
Short description
Date of birth	1963
Place of birth
Date of death
Place of death